1 / 21

The Role of Intravenous and Oral Antiplatelet Agents in Acute Coronary Syndrome

The Role of Intravenous and Oral Antiplatelet Agents in Acute Coronary Syndrome. Thank you for taking the pre-assessment. These questions will be repeated at the end of the activity. CHAMPION Trials: Study Designs. CHAMPION Trials Primary End Point and Stent Thrombosis.

vera
Download Presentation

The Role of Intravenous and Oral Antiplatelet Agents in Acute Coronary Syndrome

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. The Role of Intravenous and Oral Antiplatelet Agents in Acute Coronary Syndrome

  2. Thank you for taking the pre-assessment. These questions will be repeated at the end of the activity.

  3. CHAMPION Trials: Study Designs

  4. CHAMPION Trials Primary End Point and Stent Thrombosis

  5. Antiplatelet Therapy in ACS

  6. ADP Receptor Antagonists in ACS

  7. 2013 ACCF/AHA Guidelinefor STEMI

  8. ARCTIC No Advantage With Platelet Function- Guided Therapy

  9. Glycoprotein IIb/IIIa vs Cangrelor

  10. Pooled CHAMPION TrialsDeath, MI, IDR, Stent Thrombosis

  11. Pooled CHAMPION Trials (cont)Death, MI, IDR, Stent Thrombosis in Subgroups

  12. Pooled CHAMPION TrialsNon-CABG Bleeding at 48 h, Safety

  13. Abbreviations

  14. Abbreviations (cont)

  15. References

  16. References (cont)

  17. References (cont)

More Related